Salivary agglutinin is a high-molecular-mass component of human saliva that binds Streptococcus mutans, an oral bacterium implicated in dental caries. To study its protein sequence, we isolated the agglutinin from human parotid saliva. After trypsin digestion, a portion was analyzed by matrix assisted laser/desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS), which gave the molecular mass of 14 unique peptides. The remainder of the digest was subjected to high performance liquid chromatography, and the separated peptides were analyzed by MALDI-TOF/postsource decay; the spectra gave the sequences of 5 peptides. The molecular mass and peptide sequence information showed that salivary agglutinin peptides were identical to sequences in lung (lavage) gp-340, a member of the scavenger receptor cysteine-rich protein family. Immunoblotting with antibodies that specifically recognized either lung gp-340 or the agglutinin confirmed that the salivary agglutinin was gp-340. Immunoblotting with an antibody specific to the sialyl Le x carbohydrate epitope detected expression on the salivary, but not the lung glycoprotein, possible evidence of different glycoforms. The salivary agglutinin also interacted with Helicobacter pylori, implicated in gastritis and peptic ulcer disease, S agalactiae, implicated in neonatal meningitis, and several oral commensal streptococci. These results identify the salivary agglutinin as gp-340
INTRODUCTION
Human saliva has several critical functions, including lubrication (1-3), digestion (4), formation of a bioactive semipermeable barrier (pellicle) that coats oral surfaces (5) (6) (7) (8) , and regulation of the composition of the oral flora. Saliva fulfills the latter function by virtue of its antimicrobial activity (9, 10) and by promoting selective microbial clearance or adherence (11) (12) (13) (14) . The diverse functions attributed to saliva are allocated among its many components, which include amylases, cystatins, proline-rich proteins, proline-rich glycoproteins, carbonic anhydrases, peroxidases, statherins, histatins, lactoferrin, lysozyme, sIgA, mucins and salivary agglutinin. Protein sequences have now been deduced for all the major salivary components except the agglutinin (15) (16) (17) (18) .
Salivary agglutinin was identified as a protein fraction that mediates specific adhesion and aggregation of Streptococcus mutans (19) (20) (21) (22) . Monoclonal antibodies (mAb 1 ) to agglutinin block adherence of S. mutans to experimental pellicles and aggregation of the bacterial cells by parotid saliva (23, 24) . Several studies have related the levels of agglutinin in saliva to the numbers of S. mutans in dental plaque (19, 25) , the rate of plaque formation (26), and the susceptibility to dental caries (27). Other studies have not found these associations (28,29). Collection of Saliva-Human parotid and submandibular/sublingual (SM/SL) salivas were collected as the ductal secretions as previously described (11, 35) . The samples were either used immediately or mixed with an equal volume of loading buffer and stored at -20 o C before the experiment.
SDS-PAGE-Parotid
and SM/SL saliva samples, purified salivary agglutinin preparations and purified lung gp-340 were electrophoretically separated on polyacrylamide gels (36). Three types of gels were used. One had a 3% stacking gel and 10% running gel and the others were gradient gels, either 4-15% or 10-20% (Bio-Rad, Hercules, CA). Protein bands were visualized by staining with either Fast-stain® or Coomassie brilliant blue.
Biochemical Purification of Salivary Agglutinin-Four hundred µl of fresh parotid saliva from one donor was concentrated to 25 µl by using a Centricon-Plus 20 filter (Millipore, Marlborough, MA), then mixed with an equal volume of loading buffer. The concentrated sample was electrophoretically separated; the stacking gel contained 3% acrylamide and the 7 running gel contained 10% acrylamide. After electrophoresis, the protein bands were visualized with Fast-stain®. Under these conditions the salivary agglutinin was well separated from other proteins. This allowed excision of the M r ~350 kDa band.
Affinity Purification of Salivary Agglutinin-Agglutinin was purified from fresh parotid or SM/SL saliva using published methods (20,30). Briefly, S. mutans strain Ingbritt was maintained as described below. The cultures were harvested in exponential phase, washed once with phosphate-buffered saline (PBS; 10 mM K 2 HPO 4 /KH 2 PO 4 , 0.15 M NaCl), pH 6.8, and
suspended at a concentration of 5 x 10 9 cells/ml. Equal volumes (100 ml) of bacterial suspension and parotid or SM/SL saliva (diluted 1:1 in PBS, pH 6.8) were mixed and incubated at 37 o C for 60 min. The aggregated bacteria were pelleted by centrifugation (15,000 x g) for 30 min at 4 o C.
After the supernatant was discarded, agglutinin was released by adding 6 ml of 20 mM EDTA in PBS, pH 6.8, at room temperature. Then the sample was centrifuged (30,000 x g) for 30 min at 4 o C. The EDTA extraction and centrifugation steps were repeated once. The two supernatants were pooled and subjected to gel filtration on a Superdex 200 26/60 column (Pharmacia, Uppsala, Sweden) which was eluted with 10 mM PBS, pH 6.8. The agglutinin-containing void volume (40 ml) was concentrated to a final volume of 600 µl by using Centriprep-10 centrifugal concentrators (Amicon, Beverly, MA). The protein concentration was estimated by using the Bio-Rad DC Protein Assay (Bio-Rad, Hercules, CA) with bovine albumin as a standard. The void volume fraction was also analyzed by gradient SDS-PAGE (4-15% acrylamide).
Mass Spectrometry of Peptides Isolated from the Biochemically Purified Agglutinin-The
excised agglutinin band was macerated in a solution of high purity trypsin (0.05 µg/µl of 25 mM ammonium bicarbonate). The proteolytic digestion was allowed to continue at 37 o C for 16 h.
The resulting peptides were eluted from the gel with a solution of 50% acetonitrile and 5% trifluoroacetic acid (TFA) in distilled water and concentrated in a SpeedVac. First, the eluate was analyzed by matrix assisted laser/desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). Portions of unseparated tryptic digests were cocrystallized in a matrix of α-cyano-4-hydroxycinnamic acid and analyzed by using a PerSeptive Biosystems DE-STR MALDI-TOF mass spectrometer equipped with delayed extraction operated in the reflector mode.
Alternatively, peptide samples were subjected to high performance liquid chromatography (HPLC) separation prior to mass spectrometry. were performed essentially as previously described (38) . First, the sample was subjected to SDS-PAGE on a 10-20% gradient gel (Bio-Rad, Hercules, CA) and stained with Coomassie brilliant blue. A single band was visible near the origin of the gel. This band was excised and digested with trypsin. The peptides were analyzed by MALDI-TOF mass spectrometry on a TofSpec E instrument (Micromass, Manchester, UK) with delayed extraction and in reflectron mode, using a matrix of α-cyano-4-hydroxycinnamic acid. For MS/MS, the sample was analyzed on a Q-TOF instrument (Micromass, Manchester, UK) and the m/z 1459 ion selected for fragmentation analysis. The results were used to search sequence databases using the MS-Fit and MS-Tag programs as described above.
Immunoblotting-Following SDS-PAGE, samples were transferred to nitrocellulose or Immobilon-P membranes as previously described (39) . Briefly, non-specific binding was blocked by incubating blots for 1 h in PBS containing 0.05% Tween-20 (T-PBS) and 5%
Carnation non-fat dried milk (T-blotto). The blot was then incubated for 2 h with one of five antibodies that specifically recognized either gp-340 or salivary agglutinin: Anti-gp-340-1 was raised against a synthetic peptide that corresponds to a region of gp-340 (33). Anti-gp-340-2 and anti-gp-340-3 were raised against a gp-340 preparation purified from lung (31,32). mAbs 143 and 303 were raised against a salivary agglutinin preparation purified from saliva. An earlier study showed that mAb 143 recognizes the agglutinin protein core, whereas mAb 303 recognizes Bacteria and Culture Conditions-The origin of Streptococcus mutans strain Ingbritt was as previously described (24) . All other streptococcal strains (see Table II ) were from Dr. Mogens
Kilian (Aarhus University, Denmark). The streptococcal cells were grown as previously described (24) . The cultures were harvested at exponential phase, washed two times in PBS and suspended at a concentration of either 2 x 10 9 or 5 x 10 9 cells/ml in PBS, pH 6.8. Helicobacter pylori strain CCUG17875 was grown as previously described (40). Briefly, the cells were maintained and grown on Brucella agar supplemented with 10% bovine blood, 1% IsoVitalex,
vancomycin (10 mg/L) and trimetropin (5 mg/L). After incubation for
48 h at 37 o C in microaerophilic conditions (10% CO 2 , 5% O 2 , 85% N 2 ), the cells were harvested, washed two times in PBS and suspended at a concentration of 2 x 10 9 cells/ml in PBS.
Aggregation of Bacterial Cells by Purified Agglutinin-
The ability of affinity-purified parotid agglutinin to agglutinate a panel of streptococci (Table II) and H. pylori strain CCUG17875 was assessed as described earlier (20). Briefly, 1 ml of purified agglutinin (~ 2 µg/ml) in PBS, pH 6.8, was mixed with 1 ml of bacteria suspended at a concentration of 5x10 9 cells/ml in PBS, pH 6.8. Aggregation was recorded by measuring, at 1-min intervals for 1 h, the OD 700 using a Beckman ® DU-50 Series spectrophotometer (Beckman, Stockholm, Sweden). pelleted. An aliquot of the supernatant (~ 25 µl) was subjected to SDS-PAGE and immunoblotting with anti-gp-340-1 as described above.
Binding of Agglutinin to Bacterial

RESULTS
Isolation of Agglutinin for Mass Spectrometry Analyses-
The salivary agglutinin was isolated by two methods. The first was biochemical. Whole parotid saliva was electrophoretically separated on a SDS-polyacrylamide gel and the band corresponding to the molecular mass of the salivary agglutinin was excised (Fig. 1A, arrow head) . The second method exploited the known biological properties of the molecule. Specifically, the glycoprotein was purified by selective adsorption from whole parotid saliva to S. mutans bacteria, followed by release of bound proteins with EDTA-containing buffer, and then fractionation of the released proteins on a Superdex 200
column. SDS-PAGE of the void volume fraction showed only a single band of ~350 kDa under non-reducing conditions (Fig. 1B , lane 1, arrow head), which had a slightly lower molecular mass under reducing conditions (Fig. 1B, lane 2) . Finally, we also purified agglutinin from SM/SL saliva by selective adsorption to S. mutans cells. SDS-PAGE of the SM/SL agglutinin showed a single band with the same electrophoretic properties as the parotid agglutinin under both non-reducing (Fig. 1B, lane 3 ) and reducing conditions (Fig. 1B, lane 4) .
Analysis of the Peptide Portion of the Salivary Agglutinin by Mass Spectrometry-Initially, both
agglutinin preparations were subjected to in-gel trypsin digestion. An aliquot of each unseparated digest was analyzed by MALDI-TOF MS, which yielded a peptide mass fingerprint.
A total of 15 peptides and 14 unique sequences were obtained from the biochemically purified sample (Table I ). The sequence of 5 of these peptides was determined by MALDI-TOF/PSD (bold italic typeface in Table I ). As an example, the MALDI-TOF spectrum of one of the digests is shown in Fig. 2A . A PSD spectrum and fragmentation of the peptide m/z 1459.8 is shown in Fig. 2B , together with the interpretation and deduced amino acid sequence. The peptide mass fingerprint and PSD fragment-ions (Table I) were used for database searching. The results
showed that the peptides were identical to regions found within both gp-340 and its splice variant DMBT1, both members of the scavenger receptor cysteine-rich protein family.
The tryptic digest of the affinity-purified agglutinin sample was also analyzed by MALDI-TOF
MS. The results showed a dominant peptide of m/z 1459.8. MS/MS analyses of this peak
showed that the sequence was identical to that of the peptide of the same mass that was analyzed from the biochemically purified sample. Other ions corresponding to the peptides marked with an asterisk in Table I were also identified, as well as two additional ions at m/z 1082.2 and 2739 that correspond to peptide regions that lie toward the C-terminus of both gp-340 and DMBT1.
Together, these results show that the samples isolated by the two different methods are very likely to be the same protein.
Immunoblot Analyses of Salivary Agglutinin with Antibodies Specific for either gp-340, Salivary
Agglutinin, or the sLe x Epitope-Next, we determined whether antibodies raised against gp-340 cross-react with the salivary agglutinin. (Fig. 3B, lane 1) and affinity-purified agglutinin (Fig. 3B, lane 2) only under non-reducing conditions, as did anti-gp-340-3. Bands of the same estimated molecular mass in both samples also reacted with mAb 143, which was raised against the agglutinin protein core (data not shown). Together, the data from the immunoblot experiments suggested that the salivary agglutinin and gp-340 contained the same immunogenic regions.
During the course of the immunoblot analyses we noted that mAb 303, which recognizes the Le y epitope in the context of the agglutinin protein core (34), reacted with a single band in parotid saliva and in the affinity-purified agglutinin sample (data not shown). This result suggested the presence of specialized oligosaccharide structures. To obtain additional information about glycosylation of this molecule we surveyed expression of the sLe x epitope, which is carried by the low-molecular-weight salivary mucin and which interacts with L-selectin (42, 43) .
Interestingly, immunoblotting showed that the salivary agglutinin reacted with anti-sLe x , whereas gp-340 purified from lung did not (Fig. 3C ). This result suggested the possibility of different gp-340 glycoforms due to differences in the genotypes of the donors.
Salivary Agglutinin Interacts with a Variety of Bacteria-Next, we analyzed interactions
between salivary agglutinin and a panel of commensal and pathogenic bacteria (Table II) intermedius, several other strains of the same bacteria, as well as other streptococci that colonize dental and oral mucosal surfaces (see Table II ), were not subject to aggregation.
We were also interested in whether the agglutinin interacts with other medically important bacteria that are likely to pass through, rather than permanently colonize, the oral cavity. We were particularly interested in H. pylori, an organism implicated in gastritis and peptic ulcer disease (44, 45) . Results of these experiments showed that the salivary agglutinin also mediated aggregation of H. pylori to nearly the same extent as whole parotid saliva (Table II) .
We used a second method to confirm this potentially important observation. S. mutans and H.
pylori were incubated with parotid saliva and bound agglutinin was detected by immunoblotting with anti-gp-340-1 as described in Experimental Procedures. The results are shown in Fig. 4 .
As expected, parotid saliva (lane 1) showed an ~ 350 kDa immunoreactive band. Components of the extract of control S. mutans cells that were incubated in PBS failed to react with the antibody (Fig. 4, lane 2) , but cells incubated in parotid saliva showed an immunoreactive band of the anticipated molecular mass (Fig. 4, lane 3) . When H. pylori cells were incubated with parotid saliva or PBS, an antibody reactive band of ~350 kDa was detected only in the extract prepared from cells that were incubated with parotid saliva (Fig. 4, compare lanes 4 and 5) . The 14 unique agglutinin peptides we detected by mass spectrometry were scattered throughout the entire protein and occurred within all the major domains (see Table I ). The identification of salivary agglutinin as the gp-340 protein was also suggested by the results of immunoblotting experiments. The ~350 kDa protein we isolated from parotid saliva, by using either biochemical or affinity methods, reacted with antibodies raised against salivary agglutinin (34) and antibodies raised against lung gp-340 (31-33). Moreover, the size of the salivary molecule was the same as that of gp-340 isolated from lung lavage, evidence that the agglutinin is the full-length molecule rather than the splice variant DMBT1, which lacks 628 amino acids consisting of 5 paired SRCR and SID domains (32,46). However, we have not ruled out the possibility that the salivary molecule is a differentially glycosylated form of DMBT1. Agglutinin in parotid saliva obtained from all 6 individuals of diverse ethnic backgrounds reacted specifically with anti-gp-340 (Fig.   3A) , suggesting that expression is probably widespread in the population. However, there could be genetic variability in the expression and/or splicing of this molecule, an issue we have yet to address. In addition, differences among individuals in glycosylation seem highly likely, since the agglutinin reacted with anti-sLe x , an oligosaccharide epitope whose expression depends on genotype. Functional heterogeneity exists as well. For example, previous studies demonstrated differences among subjects with regard to agglutinin binding of S. mutans (21, 47) and that these differences coincide with susceptibility and resistance to dental caries (47) . 
mutans.
A, a sample of whole parotid saliva was separated on a 10% polyacrylamide gel as described in "Experimental Procedures." The band of 350 kDa, denoted by the arrow head, was excised and subjected to an in-gel trypsin digest, prior to analysis by mass spectrometry (see Fig.   2 and Table I ). B, salivary agglutinin (single band denoted with an arrow head) was also isolated from saliva by adsorption to S. mutans. SDS-PAGE (4-15% gradient gel) of the glycoproteins that were purified from parotid (lanes 1 and 2) and SM/SL saliva (lanes 3 and 4) . Under both non-reducing (B, lanes 1 and 3) and reducing conditions (B, lanes 2 and 4) the agglutinin appeared as a single band, with a slightly lower molecular mass under reducing conditions.
Proteins were visualized by staining with either Fast-stain® (A) or Coomassie brilliant blue (B).
The top and bottom of the stacking gels are marked with arrows. ions were observed due to loss of H 2 O. C, peptides also present in a negative control, a portion of the polyacrylamide gel that did not stain for protein; T, trypsin autoproteolysis peptides which were used to internally calibrate the spectrum. 2-7) . The top and bottom of the stacking gels are marked with arrows. The biochemically purified salivary agglutinin was subjected to in-gel trypsin digestion and an aliquot of the unseparated digest was analyzed by MALDI-TOF MS, which gave the molecular mass of 15 peptides. The remainder of the digest was subjected to high performance liquid chromatography, and the separated peptides were analyzed by MALDI-TOF/PSD; the spectra showed the sequences of 5 peptides (bold italicized typeface). 
